Ignite Creation Date:
2024-05-06 @ 12:23 PM
Last Modification Date:
2024-10-26 @ 12:58 PM
Study NCT ID:
NCT03746912
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2020-04-15
First Post:
2018-11-15
Brief Title:
Expanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia AML to Receive Quizartinib
Sponsor:
Organization:
Daiichi Sankyo